American Journal of Kidney Diseases, ISSN 0272-6386, 2016, Volume 68, Issue 6, pp. 989 - 990
Journal Article
Transplantation direct, ISSN 2373-8731, 10/2018, Volume 4, Issue 10, p. e394
The process of evaluating candidates for living kidney donation can be inefficient. A structured review of existing information on this topic can provide a...
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2009, Volume 53, Issue 6, pp. 961 - 973
Background Acute kidney injury (AKI) is common in hospitalized patients. The impact of AKI on long-term outcomes is controversial. Study Design Systematic...
Nephrology | prognosis | chronic kidney disease | Acute renal failure | HOSPITAL MORTALITY | ACUTE-RENAL-FAILURE | ACUTE TUBULAR-NECROSIS | PERCUTANEOUS CORONARY INTERVENTION | PERITUBULAR CAPILLARIES | INTENSIVE-CARE-UNIT | REPLACEMENT THERAPY | UROLOGY & NEPHROLOGY | CONTINUOUS VENOVENOUS HEMODIALYSIS | QUALITY-OF-LIFE | CRITICALLY-ILL PATIENTS | Acute Kidney Injury - mortality | Time Factors | Humans | Risk Factors | Treatment Outcome | Acute Kidney Injury - therapy | Mortality - trends
Nephrology | prognosis | chronic kidney disease | Acute renal failure | HOSPITAL MORTALITY | ACUTE-RENAL-FAILURE | ACUTE TUBULAR-NECROSIS | PERCUTANEOUS CORONARY INTERVENTION | PERITUBULAR CAPILLARIES | INTENSIVE-CARE-UNIT | REPLACEMENT THERAPY | UROLOGY & NEPHROLOGY | CONTINUOUS VENOVENOUS HEMODIALYSIS | QUALITY-OF-LIFE | CRITICALLY-ILL PATIENTS | Acute Kidney Injury - mortality | Time Factors | Humans | Risk Factors | Treatment Outcome | Acute Kidney Injury - therapy | Mortality - trends
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2014, Volume 63, Issue 3, pp. 464 - 478
Background Advantages of the arteriovenous fistula (AVF), including long patency and few complications, were ascertained more than 2 decades ago and may not...
Nephrology | patency | epidemiology and outcomes | Hemodialysis | fistula | primary failure | vascular access | UNITED-STATES | SURVIVAL | MATURATION | VASCULAR ACCESS OUTCOMES | MAINTENANCE | BASILIC VEIN | UROLOGY & NEPHROLOGY | EXPERIENCE | DIALYSIS FISTULAS | TRANSPOSED BRACHIOBASILIC FISTULAS | EARLY FAILURE | Kidney Failure, Chronic - therapy | Arteriovenous Shunt, Surgical - standards | Humans | Risk Factors | Renal Dialysis - methods | Vascular Patency
Nephrology | patency | epidemiology and outcomes | Hemodialysis | fistula | primary failure | vascular access | UNITED-STATES | SURVIVAL | MATURATION | VASCULAR ACCESS OUTCOMES | MAINTENANCE | BASILIC VEIN | UROLOGY & NEPHROLOGY | EXPERIENCE | DIALYSIS FISTULAS | TRANSPOSED BRACHIOBASILIC FISTULAS | EARLY FAILURE | Kidney Failure, Chronic - therapy | Arteriovenous Shunt, Surgical - standards | Humans | Risk Factors | Renal Dialysis - methods | Vascular Patency
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2016, Volume 130, Issue 2, pp. 163 - 172.e4
Abstract Background The risk of hospital readmission in acute kidney injury survivors is not well understood. We estimated the proportion of acute kidney...
Internal Medicine | Care transitions | Hospital readmissions | Acute kidney injury | Quality of care | MORTALITY | RISK | ACUTE-RENAL-FAILURE | DEATH | DIALYSIS | MEDICINE, GENERAL & INTERNAL | OUTCOMES | ASSOCIATION | EPIDEMIOLOGY | AKI | Comorbidity | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Hospitalization - statistics & numerical data | Male | Propensity Score | Acute Kidney Injury - mortality | Time Factors | Aged, 80 and over | Female | Acute Kidney Injury - therapy | Aged | Patient Readmission - statistics & numerical data | Ontario | Medical policy | Medical colleges | Management science | Analysis | Information management | Research institutes | Kidney diseases | Medical research | Clinics | Medicine, Experimental | Medical care | Quality management
Internal Medicine | Care transitions | Hospital readmissions | Acute kidney injury | Quality of care | MORTALITY | RISK | ACUTE-RENAL-FAILURE | DEATH | DIALYSIS | MEDICINE, GENERAL & INTERNAL | OUTCOMES | ASSOCIATION | EPIDEMIOLOGY | AKI | Comorbidity | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Hospitalization - statistics & numerical data | Male | Propensity Score | Acute Kidney Injury - mortality | Time Factors | Aged, 80 and over | Female | Acute Kidney Injury - therapy | Aged | Patient Readmission - statistics & numerical data | Ontario | Medical policy | Medical colleges | Management science | Analysis | Information management | Research institutes | Kidney diseases | Medical research | Clinics | Medicine, Experimental | Medical care | Quality management
Journal Article
Annals of Thoracic Surgery, ISSN 0003-4975, 2017, Volume 104, Issue 2, pp. 613 - 620
Background Monocyte chemotactic protein-1 (MCP-1; chemokine C-C ligand-2 [CCL-2]) is upregulated in ischemia-reperfusion injury and is a promising biomarker of...
Surgery | Cardiothoracic Surgery | SURGERY | BYPASS GRAFTING SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR EVENTS | CARDIOPULMONARY BYPASS | NATRIURETIC PEPTIDE | ISCHEMIA-REPERFUSION INJURY | BIOMARKERS | TRIAL | RESPIRATORY SYSTEM | CHEMOATTRACTANT PROTEIN-1 | OUTCOMES | INFLAMMATORY CYTOKINES | Risk Assessment - methods | United States - epidemiology | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Postoperative Complications - blood | Male | Cardiac Surgical Procedures - adverse effects | Incidence | Female | Heart Diseases - blood | Odds Ratio | Acute Kidney Injury - etiology | Survival Rate - trends | Acute Kidney Injury - blood | Risk Factors | Postoperative Complications - epidemiology | Biomarkers - blood | Chemokine CCL2 - blood | Heart Diseases - mortality | Ontario - epidemiology | Cause of Death - trends | Aged | Acute Kidney Injury - epidemiology | Heart Diseases - surgery | Preoperative Period
Surgery | Cardiothoracic Surgery | SURGERY | BYPASS GRAFTING SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR EVENTS | CARDIOPULMONARY BYPASS | NATRIURETIC PEPTIDE | ISCHEMIA-REPERFUSION INJURY | BIOMARKERS | TRIAL | RESPIRATORY SYSTEM | CHEMOATTRACTANT PROTEIN-1 | OUTCOMES | INFLAMMATORY CYTOKINES | Risk Assessment - methods | United States - epidemiology | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Postoperative Complications - blood | Male | Cardiac Surgical Procedures - adverse effects | Incidence | Female | Heart Diseases - blood | Odds Ratio | Acute Kidney Injury - etiology | Survival Rate - trends | Acute Kidney Injury - blood | Risk Factors | Postoperative Complications - epidemiology | Biomarkers - blood | Chemokine CCL2 - blood | Heart Diseases - mortality | Ontario - epidemiology | Cause of Death - trends | Aged | Acute Kidney Injury - epidemiology | Heart Diseases - surgery | Preoperative Period
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2010, Volume 57, Issue 1, pp. 29 - 43
Background Information in health administrative databases increasingly guides renal care and policy. Study Design Systematic review of observational studies....
Nephrology | renal | coding | Administrative database | validity | INTERNATIONAL-CLASSIFICATION | OUTCOMES RESEARCH | 9TH REVISION | ACUTE-RENAL-FAILURE | CLASSIFICATION-OF-DISEASES | BYPASS GRAFT-SURGERY | CLINICAL-MODIFICATION CODES | CLAIMS DATA | UROLOGY & NEPHROLOGY | META-REGRESSION | HOSPITAL DISCHARGE DATA | Canada | Kidney Diseases - classification | United States | Humans | Sensitivity and Specificity | Australia | Health Services Research | Clinical Coding | Databases, Factual | Spain
Nephrology | renal | coding | Administrative database | validity | INTERNATIONAL-CLASSIFICATION | OUTCOMES RESEARCH | 9TH REVISION | ACUTE-RENAL-FAILURE | CLASSIFICATION-OF-DISEASES | BYPASS GRAFT-SURGERY | CLINICAL-MODIFICATION CODES | CLAIMS DATA | UROLOGY & NEPHROLOGY | META-REGRESSION | HOSPITAL DISCHARGE DATA | Canada | Kidney Diseases - classification | United States | Humans | Sensitivity and Specificity | Australia | Health Services Research | Clinical Coding | Databases, Factual | Spain
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2016, Volume 68, Issue 4, pp. 591 - 598
Background Patients who require dialysis are at high risk for cardiovascular mortality, which may be improved by mineralocorticoid receptor antagonists (MRAs)....
Nephrology | blood pressure | eplerenone | aldosterone | hyperkalemia | meta-analysis | adverse events | randomized controlled trials | systematic review | spironolactone | cardiovascular death | Mineralocorticoid receptor antagonist (MRA) | end-stage renal disease (ESRD) | all-cause mortality | hemodialysis | peritoneal dialysis | HEART-FAILURE | TIME | RANDOMIZED CONTROLLED-TRIAL | CLINICAL-TRIALS | HEMODIALYSIS-PATIENTS | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | PLACEBO-CONTROLLED TRIAL | HYPERTENSION | Cardiovascular Diseases - prevention & control | Humans | Cardiovascular Diseases - mortality | Mineralocorticoid Receptor Antagonists - adverse effects | Spironolactone - analogs & derivatives | Spironolactone - therapeutic use | Cause of Death | Mineralocorticoid Receptor Antagonists - therapeutic use | Randomized Controlled Trials as Topic | Renal Dialysis
Nephrology | blood pressure | eplerenone | aldosterone | hyperkalemia | meta-analysis | adverse events | randomized controlled trials | systematic review | spironolactone | cardiovascular death | Mineralocorticoid receptor antagonist (MRA) | end-stage renal disease (ESRD) | all-cause mortality | hemodialysis | peritoneal dialysis | HEART-FAILURE | TIME | RANDOMIZED CONTROLLED-TRIAL | CLINICAL-TRIALS | HEMODIALYSIS-PATIENTS | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | PLACEBO-CONTROLLED TRIAL | HYPERTENSION | Cardiovascular Diseases - prevention & control | Humans | Cardiovascular Diseases - mortality | Mineralocorticoid Receptor Antagonists - adverse effects | Spironolactone - analogs & derivatives | Spironolactone - therapeutic use | Cause of Death | Mineralocorticoid Receptor Antagonists - therapeutic use | Randomized Controlled Trials as Topic | Renal Dialysis
Journal Article
Canadian Medical Association Journal, ISSN 0820-3946, 2019, Volume 191, Issue 9, pp. E247 - E256
ABSTRACT BACKGROUND Perioperative corticosteroid use may reduce acute kidney injury. We sought to test whether methylprednisolone reduces the risk of acute...
Internal Medicine | SIRS | MEDICINE, GENERAL & INTERNAL | STEROIDS | HIGH-DOSE DEXAMETHASONE | Corticosteroids | Chronic kidney failure | Coronary artery bypass | Risk assessment | Surgery | Cardiac patients | Aprotinin | Methylprednisolone | Steroids | Heart | Complications and side effects | Care and treatment | Usage | Heart, Mechanical | Health aspects | Acute renal failure | Research
Internal Medicine | SIRS | MEDICINE, GENERAL & INTERNAL | STEROIDS | HIGH-DOSE DEXAMETHASONE | Corticosteroids | Chronic kidney failure | Coronary artery bypass | Risk assessment | Surgery | Cardiac patients | Aprotinin | Methylprednisolone | Steroids | Heart | Complications and side effects | Care and treatment | Usage | Heart, Mechanical | Health aspects | Acute renal failure | Research
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2016, Volume 69, Issue 1, pp. 87 - 96
Background Hyponatremia may occur after initiation of a second-generation antidepressant drug. However, the magnitude of this risk among older adults in...
Nephrology | second-generation antidepressant | syndrome of inappropriate antidiuretic hormone secretion (SIADH) | mirtazapine | Hyponatremia | mood disorder | antidepressants | fluvoxamine | serum sodium | paroxetine | fluoxetine | venlafaxine | older adults | escitalopram | duloxetine | anxiety disorder | electrolyte disorder | citalopram | sertraline | ADVERSE OUTCOMES | DRUGS | PROPENSITY SCORE | HYPERNATREMIA | SEROTONIN-REUPTAKE INHIBITORS | UROLOGY & NEPHROLOGY | MAJOR DEPRESSIVE DISORDER | CHRONIC KIDNEY-DISEASE | CONGESTIVE-HEART-FAILURE | ELDERLY-PATIENTS | EPIDEMIOLOGY | Hyponatremia - chemically induced | Antidepressive Agents, Second-Generation - adverse effects | Hyponatremia - epidemiology | Risk Assessment | Time Factors | Humans | Hospitalization - statistics & numerical data | Female | Male | Aged | Retrospective Studies | Cohort Studies
Nephrology | second-generation antidepressant | syndrome of inappropriate antidiuretic hormone secretion (SIADH) | mirtazapine | Hyponatremia | mood disorder | antidepressants | fluvoxamine | serum sodium | paroxetine | fluoxetine | venlafaxine | older adults | escitalopram | duloxetine | anxiety disorder | electrolyte disorder | citalopram | sertraline | ADVERSE OUTCOMES | DRUGS | PROPENSITY SCORE | HYPERNATREMIA | SEROTONIN-REUPTAKE INHIBITORS | UROLOGY & NEPHROLOGY | MAJOR DEPRESSIVE DISORDER | CHRONIC KIDNEY-DISEASE | CONGESTIVE-HEART-FAILURE | ELDERLY-PATIENTS | EPIDEMIOLOGY | Hyponatremia - chemically induced | Antidepressive Agents, Second-Generation - adverse effects | Hyponatremia - epidemiology | Risk Assessment | Time Factors | Humans | Hospitalization - statistics & numerical data | Female | Male | Aged | Retrospective Studies | Cohort Studies
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2017, Volume 70, Issue 1, pp. 59 - 68
Background Bedside estimates of the risk for hypoglycemia by estimated glomerular filtration rate (eGFR), urine albumin-creatinine ratio (ACR), and use of...
Nephrology | epidemiology | antihyperglycemic medications | outcomes | hospital encounter | elderly | estimated glomerular filtration rate (eGFR) | older adults | renal function | kidney disease | Hypoglycemia | glycated hemoglobin (HbA1c) | urinary albumin-creatinine ratio (UACR) | glycated hemoglobin (HbA | urinary albumincreatinine ratio (UACR) | PREVALENCE | DIABETES-MELLITUS | INSULIN | FREQUENCY | UROLOGY & NEPHROLOGY | CHRONIC KIDNEY-DISEASE | TYPE-1 | ASSOCIATION | RENAL-INSUFFICIENCY | Hypoglycemic Agents - therapeutic use | Hypoglycemia - epidemiology | Glomerular Filtration Rate | Humans | Male | Incidence | Hypoglycemia - physiopathology | Ontario - epidemiology | Aged, 80 and over | Female | Aged | Retrospective Studies | Cohort Studies
Nephrology | epidemiology | antihyperglycemic medications | outcomes | hospital encounter | elderly | estimated glomerular filtration rate (eGFR) | older adults | renal function | kidney disease | Hypoglycemia | glycated hemoglobin (HbA1c) | urinary albumin-creatinine ratio (UACR) | glycated hemoglobin (HbA | urinary albumincreatinine ratio (UACR) | PREVALENCE | DIABETES-MELLITUS | INSULIN | FREQUENCY | UROLOGY & NEPHROLOGY | CHRONIC KIDNEY-DISEASE | TYPE-1 | ASSOCIATION | RENAL-INSUFFICIENCY | Hypoglycemic Agents - therapeutic use | Hypoglycemia - epidemiology | Glomerular Filtration Rate | Humans | Male | Incidence | Hypoglycemia - physiopathology | Ontario - epidemiology | Aged, 80 and over | Female | Aged | Retrospective Studies | Cohort Studies
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2007, Volume 50, Issue 5, pp. 712 - 720
Background Recently, acute kidney injury defined by small changes in serum creatinine levels was associated with worse short-term outcomes; however, the...
Nephrology | Kidney failure, acute | critical illness | thoracic surgery | heart failure, congestive | acute | heart failure | ATRIAL-NATRIURETIC-PEPTIDE | HEART-FAILURE | kidney failure | ACUTE-RENAL-FAILURE | ACUTE TUBULAR-NECROSIS | congestive | SERUM CYSTATIN-C | PUBLICATION BIAS | CARDIAC-SURGERY | REPLACEMENT THERAPY | UROLOGY & NEPHROLOGY | CRITICALLY-ILL PATIENTS | GROWTH-FACTOR-I | Prognosis | Comorbidity | Acute Kidney Injury - blood | Humans | Creatinine - blood | Hospitalization | Acute Kidney Injury - epidemiology | Heart Failure - epidemiology | Kidney Function Tests
Nephrology | Kidney failure, acute | critical illness | thoracic surgery | heart failure, congestive | acute | heart failure | ATRIAL-NATRIURETIC-PEPTIDE | HEART-FAILURE | kidney failure | ACUTE-RENAL-FAILURE | ACUTE TUBULAR-NECROSIS | congestive | SERUM CYSTATIN-C | PUBLICATION BIAS | CARDIAC-SURGERY | REPLACEMENT THERAPY | UROLOGY & NEPHROLOGY | CRITICALLY-ILL PATIENTS | GROWTH-FACTOR-I | Prognosis | Comorbidity | Acute Kidney Injury - blood | Humans | Creatinine - blood | Hospitalization | Acute Kidney Injury - epidemiology | Heart Failure - epidemiology | Kidney Function Tests
Journal Article
Journal of Thoracic and Cardiovascular Surgery, The, ISSN 0022-5223, 2016, Volume 152, Issue 1, pp. 245 - 251.e4
Abstract Background Acute kidney injury (AKI) is common after cardiac surgery and is associated with post-operative mortality. Perioperative cardiac biomarkers...
Cardiothoracic Surgery | brain natriuretic peptide | mortality | cardiac surgery | acute kidney injury | troponin | biomarkers | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | METAANALYSIS | HEART-FAILURE | ACUTE-RENAL-FAILURE | ADVERSE OUTCOMES | RELEASE | BYPASS GRAFT-SURGERY | NATRIURETIC PEPTIDE | PROGNOSTIC VALUE | RESPIRATORY SYSTEM | United States - epidemiology | Prospective Studies | Follow-Up Studies | Acute Kidney Injury - blood | Humans | Male | Cardiac Surgical Procedures - adverse effects | Biomarkers - blood | Incidence | Troponin I - blood | Troponin T - blood | Ontario - epidemiology | Peptide Fragments - blood | Creatine Kinase, MB Form - blood | Female | Aged | Acute Kidney Injury - epidemiology | Postoperative Complications | Acute Kidney Injury - etiology | Heart Diseases - surgery | Natriuretic Peptide, Brain - blood | Biological markers | Health aspects | Mortality | Analysis | Coronary artery bypass | Creatine | Natriuretic peptides | Biomarkers | Acute Kidney Injury | Troponin | Cardiac Surgery | BNP
Cardiothoracic Surgery | brain natriuretic peptide | mortality | cardiac surgery | acute kidney injury | troponin | biomarkers | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | METAANALYSIS | HEART-FAILURE | ACUTE-RENAL-FAILURE | ADVERSE OUTCOMES | RELEASE | BYPASS GRAFT-SURGERY | NATRIURETIC PEPTIDE | PROGNOSTIC VALUE | RESPIRATORY SYSTEM | United States - epidemiology | Prospective Studies | Follow-Up Studies | Acute Kidney Injury - blood | Humans | Male | Cardiac Surgical Procedures - adverse effects | Biomarkers - blood | Incidence | Troponin I - blood | Troponin T - blood | Ontario - epidemiology | Peptide Fragments - blood | Creatine Kinase, MB Form - blood | Female | Aged | Acute Kidney Injury - epidemiology | Postoperative Complications | Acute Kidney Injury - etiology | Heart Diseases - surgery | Natriuretic Peptide, Brain - blood | Biological markers | Health aspects | Mortality | Analysis | Coronary artery bypass | Creatine | Natriuretic peptides | Biomarkers | Acute Kidney Injury | Troponin | Cardiac Surgery | BNP
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2015, Volume 67, Issue 6, pp. 902 - 911
Background β-Blocking agents reduce cardiovascular mortality in patients with heart disease, but their potential benefit in dialysis patients is unclear. We...
Nephrology | dialysis | adrenergic receptor blockade | drug tolerability | Dilatrend | randomized controlled trial (RCT) | carvedilol | cardiovascular mortality | feasibility study | Beta-blocker | hemodialysis | intradialytic hypotension (IDH) | end-stage kidney disease (ESKD) | study recruitment | bradycardia | cardiovascular disease (CVD) | MORTALITY | THROMBUS ASPIRATION | TYPE-2 DIABETES-MELLITUS | ELEVATION MYOCARDIAL-INFARCTION | DILATED CARDIOMYOPATHY | REGISTRY TRIAL | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | PLACEBO-CONTROLLED TRIAL | CHRONIC KIDNEY-DISEASE | Cardiovascular Diseases - etiology | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Feasibility Studies | Kidney Failure, Chronic - therapy | Propanolamines - therapeutic use | Kidney Failure, Chronic - complications | Female | Aged | Carbazoles - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Renal Dialysis
Nephrology | dialysis | adrenergic receptor blockade | drug tolerability | Dilatrend | randomized controlled trial (RCT) | carvedilol | cardiovascular mortality | feasibility study | Beta-blocker | hemodialysis | intradialytic hypotension (IDH) | end-stage kidney disease (ESKD) | study recruitment | bradycardia | cardiovascular disease (CVD) | MORTALITY | THROMBUS ASPIRATION | TYPE-2 DIABETES-MELLITUS | ELEVATION MYOCARDIAL-INFARCTION | DILATED CARDIOMYOPATHY | REGISTRY TRIAL | HEMODIALYSIS-PATIENTS | UROLOGY & NEPHROLOGY | PLACEBO-CONTROLLED TRIAL | CHRONIC KIDNEY-DISEASE | Cardiovascular Diseases - etiology | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Feasibility Studies | Kidney Failure, Chronic - therapy | Propanolamines - therapeutic use | Kidney Failure, Chronic - complications | Female | Aged | Carbazoles - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Renal Dialysis
Journal Article